Dystonia 21

disease
On this page

Also known as dystonia type 21DYT21

Summary

Dystonia 21 (MONDO:0013813) is a disease. A subtype of generalized dystonia — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
  • Phenotypes (HPO): 9

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Cases/families16WorldwideValidated
Point prevalence<1 / 1 000 000WorldwideValidated

Signs & symptoms

Clinical features (HPO)

9 HPO clinical features (Orphanet curated; top 9 by frequency):

HPO IDTermFrequency
HP:0001332DystoniaVery frequent (80-99%)
HP:0000473TorticollisFrequent (30-79%)
HP:0000643BlepharospasmFrequent (30-79%)
HP:0002268Paroxysmal dystoniaFrequent (30-79%)
HP:0004373Focal dystoniaFrequent (30-79%)
HP:0007325Generalized dystoniaFrequent (30-79%)
HP:0002451Limb dystoniaOccasional (5-29%)
HP:0002530Axial dystoniaOccasional (5-29%)
HP:0012049Laryngeal dystoniaOccasional (5-29%)

Identifiers

Disease identifiers

FieldValue
Canonical namedystonia 21
Mondo IDMONDO:0013813
OMIM614588
Orphanet306734
DOIDDOID:0090046
UMLSC3281236
MedGen482866
GARD0017383
Is cancer (heuristic)no

Also known as: dystonia 21 · dystonia type 21 · DYT21

Disease family

This is a subtype of generalized dystonia. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disordermovement disorderextrapyramidal and movement diseasedystonic disorderinherited dystoniaisolated dystoniageneralized dystoniadystonia 21

Related subtypes (2): torsion dystonia 6, early-onset generalized dystonia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.